Skip to content

Opening book details…

About this Medicine article

Development of flow cytometric predictive biomarker assay for response to PARP inhibitor (PARPi) therapy in high-grade serous ovarian cancer (HGSOC) by Lee, J.M.; Gordon, N.; Lee, M.J.; Trepel, J.; Yu, M.; Kohn, E.C. is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Lee, J.M.; Gordon, N.; Lee, M.J.; Trepel, J.; Yu, M.; Kohn, E.C.
Publisher
Elsevier Science; Elsevier ; Elsevier Inc.; Elsevier BV (ISSN 0090-8258)
Published
2014
Field
Medicine (Health Sciences)

More by Lee, J.M.; Gordon, N.; Lee, M.J.; Trepel, J.; Yu, M.; Kohn, E.C.

Browse all works by Lee, J.M.; Gordon, N.; Lee, M.J.; Trepel, J.; Yu, M.; Kohn, E.C.